Candida krusei


Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.
Related to Candida krusei: Candida albicans, Candida glabrata

Candida krusei

a fluconazole-resistant species of Candida.

Candida krusei

an extremely rare non-albicans species of Candida occasionally associated with candidiasis, esophagitis, endocarditis, and vaginitis.

Candida krusei

A Candida species responsible for bloodborne, cardiac, and ocular infections, esp. in immunocompromised patients. It is resistant to fluconazole.
See also: Candida
References in periodicals archive ?
65 Each value is presented as mean [+ or -] standard deviation (n = 3) Table 2: Antifungal activity of algal species Candida Albicans Glabrata Algae extract Padina Pavonica Total - - Petroleum ether - - Ethyl acetate - ++ Butanol aqueous - - Sargassum Vulgare Total - - Petroleum ether - - Ethyl acetate - - Butanol aqueous - - Candida Krusei Tropicalis Algae extract Padina Pavonica Total - - Petroleum ether - - Ethyl acetate + - Butanol aqueous - - Sargassum Vulgare Total - - Petroleum ether - - Ethyl acetate - - Butanol aqueous - - Table 3: Total phenolic content (mg Gallic acid equivalents (GAE/g extract) of total extract and fractions.
Species differentiation by internally transcribed spacer PCR and HhaI digestion of fluconazole-resistant Candida krusei, Candida inconspicua, and Candida norvegensis strains.
NYOTRAN was additive in combination with itraconazole or flucytosine against three Candida krusei isolates, and was additive in combination with amphotericin B against two out of three Aspergillus fumigatus isolates.
The yeasts Candida albicans and Candida krusei may occur in low frequency on skin and mucous membranes without causing symptoms.
The stomach cultures grew multiple Candida glabrata and few Candida krusei.
Antifungal activity of the chloroform extract of Hypericum ternum against Candida spp Hypericum ternum (chloroform) Amphotericin B Ketoconazole Candida tropicalis 250 15 3 (CEREMIC 131-2000) Candida parapsilosis 1000 30 25 (CEREMIC 118-2000) Candida glabrata 500 30 5 (CEREMIC 115-2000) Candida lusitaniae 1000 10 10 (CEREMIC 124-2000) Candida krusei 500 0.
Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use.
glabrata) 35234 Candida glabrata II hemoculture 35202 Candida glabrata III hemoculture 36293 Candida krusei I laryngeal prothesis Candida krusei II urineculture 38495 Candida parapsilosis I hemoculture 35416 Candida parapsilosis II hemoculture 15760 Candida tropicalis hemoculture 16819 Cryptococcus neoformans CSF (HIV patient) 20772 Aspergillus fumigatus nasal polyps (fungal sinusitis) Aspergillus flavus nasal swab (in leukemic patient) Superficial mycosis Trychophyton rubrum Tinea pedis (male patient) Trychophyton toe nail mentagrophytes Epidermophyton foccosum Tinea pedis (a year evolution in HIV patient) Microorganism Inhibition Diameter (mm) I.